Filgrastim News
Filgrastim currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Filgrastim with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Ratiograstim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with...
- Evidence level: L2
- Predicted indications (20):
- primary release disorder of platelets (100.0%)
- pseudo-von Willebrand disease (100.0%)
- Glanzmann thrombasthenia (100.0%)
- Scott syndrome (100.0%)
- hemorrhagic disorder due to a constitutional thrombocytopenia (99.9%)
- bleeding diathesis due to a collagen receptor defect (99.9%)
- C1 inhibitor deficiency (99.8%)
- serpinopathy with toxic serpin polymerization (99.8%)
- fetal and neonatal alloimmune thrombocytopenia (99.8%)
- platelet-type bleeding disorder (99.7%)
- hereditary angioedema with C1Inh deficiency (99.7%)
- Ehlers-Danlos syndrome, fibronectinemic type (99.6%)
- severe congenital neutropenia (99.6%)
- Peyronie disease (99.6%)
- primary immunodeficiency syndrome due to p14 deficiency (99.6%)
- cyclic hematopoiesis (99.5%)
- mixed-type autoimmune hemolytic anemia (99.4%)
- proteinuria (99.4%)
- primary CD59 deficiency (99.4%)
- drug-induced autoimmune hemolytic anemia (99.4%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.